- Home
- PPBT vs VMAR Comparison
PPBT vs VMAR Comparison
Compare PPBT & VMAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PPBT
- VMAR
- Stock Information
- Founded
- PPBT 2010
- VMAR 1995
- Country
- PPBT Israel
- VMAR Canada
- Employees
- PPBT N/A
- VMAR N/A
- Industry
- PPBT Biotechnology: Pharmaceutical Preparations
- VMAR Marine Transportation
- Sector
- PPBT Health Care
- VMAR Industrials
- Exchange
- PPBT Nasdaq
- VMAR Nasdaq
- Market Cap
- PPBT 6.3M
- VMAR 5.1M
- IPO Year
- PPBT N/A
- VMAR 2020
- Fundamental
- Price
- PPBT $2.62
- VMAR $7.42
- Analyst Decision
- PPBT Strong Buy
- VMAR Strong Buy
- Analyst Count
- PPBT 1
- VMAR 1
- Target Price
- PPBT $33.00
- VMAR $2,700.00
- AVG Volume (30 Days)
- PPBT 30.8K
- VMAR 32.4K
- Earning Date
- PPBT 05-21-2025
- VMAR 07-14-2025
- Dividend Yield
- PPBT N/A
- VMAR N/A
- EPS Growth
- PPBT N/A
- VMAR N/A
- EPS
- PPBT N/A
- VMAR N/A
- Revenue
- PPBT N/A
- VMAR $1,612,492.00
- Revenue This Year
- PPBT N/A
- VMAR N/A
- Revenue Next Year
- PPBT N/A
- VMAR $264.29
- P/E Ratio
- PPBT N/A
- VMAR N/A
- Revenue Growth
- PPBT N/A
- VMAR N/A
- 52 Week Low
- PPBT $2.00
- VMAR $4.04
- 52 Week High
- PPBT $13.95
- VMAR $1,025.33
- Technical
- Relative Strength Index (RSI)
- PPBT 56.64
- VMAR 52.71
- Support Level
- PPBT $2.46
- VMAR $6.81
- Resistance Level
- PPBT $2.80
- VMAR $8.17
- Average True Range (ATR)
- PPBT 0.20
- VMAR 0.69
- MACD
- PPBT 0.04
- VMAR 0.02
- Stochastic Oscillator
- PPBT 66.96
- VMAR 45.52
About PPBT Purple Biotech Ltd.
Purple Biotech Ltd is a clinical-stage company focused on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, and to create treatments for people with cancer. Its oncology pipeline includes NT219: A dual inhibitor, small molecule that simultaneously targets Insulin Receptor Substrate 1 and 2 (IRS1/2) and Signal Transducer and Activator of Transcription (STAT3), two survival signal transduction pathways driving the development of cancer drug resistance. and CM24: is a humanized monoclonal antibody designed to block the interactions of Carcinoembryonic Antigen Related Cell Adhesion Molecule 1 (CEACAM1), a glycoprotein that plays a key role in immune regulation, cell adhesion, and tumor progression, CAPTN3.
About VMAR Vision Marine Technologies Inc.
Vision Marine Technologies Inc is in the business of designing and manufacturing electric outboard powertrain systems, power boats, and related technology and the renting of electric boats. The different models of the powerboats and electric boats manufactured by the company include Bruce 22, Fantail 217, Volt 180, and others. The company operates in two reportable business segments; Sale of electric boats and Rental of electric boats. The majority of the revenue for the company is generated from the Sale of electric boats segment. Geographically, the company generates revenue from its business in Canada, USA and other countries. A substantial portion of the overall revenue is generated from its business in USA.